COYA vs EIX · rev $3.6M vs P/E 7.3, rev $17.60B
Coya Therapeutics, Inc. Common Stock (COYA) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported COYA revenue for 2024-12-31 was $3.6M. Net income was -$14.9M. Revenue was down 40.8% from 2023-12-31 to 2024-12-31. COYA currently screens at market cap $118.0M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
COYA currently screens at market cap $118.0M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the COYA and EIX stock pages for the full models.
Not investment advice.